| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |